The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient

PloS One
Yang LiYanxin Li

Abstract

p53 is one of the most extensively studied proteins in cancer research. Mutations in p53 generally abolish normal p53 function, and some mutants can gain new oncogenic functions. However, the mechanisms underlying p53 mutation-driven cancer remains to be elucidated. Our study investigated the function of a heterozygous p53 mutation (p.Asn268Glufs*4) in a Li-Fraumeni syndrome (LFS) patient. We used episomal technology to perform somatic reprogramming, and used molecular and cell biology methods to determine the p53 mutation levels in patient-originated induced pluripotent stem (iPS) cells at the RNA and protein levels. We found that p53 protein expression was not increased in this patient's somatic cells compared with those of a healthy control. p53 mutation facilitates the proliferation of tumor cells by inhibiting apoptosis and promoting cell division. It can inhibit the efficiency of somatic reprogramming by inhibiting OCT4 expression during reprogramming stage. Moreover, not all p53 mutant iPS cell lines have mutant p53 RNA sequences. A small percentage of mutant p53 mRNA is present in the somatic cells from the patient and his mother. In summary, this p53 mutation can promote tumor cell proliferation, inhibit somatic reprog...Continue Reading

References

Jan 1, 1991·Journal of Cellular Biochemistry·D MichalovitzM Oren
Mar 3, 1995·Science·S M CrossB J Reid
Feb 18, 2004·PLoS Biology·Peter Hohenstein
Sep 1, 2005·Genes & Development·Jean-Christophe BourdonDavid P Lane
Mar 24, 2007·Nature Reviews. Molecular Cell Biology·Karen H Vousden, David P Lane
Apr 16, 2008·Annual Review of Biochemistry·Andreas C Joerger, Alan R Fersht
Aug 12, 2008·Cell·In-Hyun ParkGeorge Q Daley
Aug 12, 2009·Nature·Teruhisa KawamuraJuan Carlos Izpisúa Belmonte
Aug 29, 2009·Nature·Valery Krizhanovsky, Scott W Lowe
Oct 28, 2009·Nature Reviews. Genetics·Juan Carlos Izpisúa BelmonteShinya Yamanaka
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jennifer P MortonOwen J Sansom
Jun 21, 2011·Human Genetics·Martin Escamilla-Del-ArenalEdith Heard
Feb 22, 2012·Genome Biology·Lillian M ZwemerAlexander A Gimelbrant
Jul 23, 2013·Nature Communications·Yanxin LiTao Cheng
Mar 1, 2014·Developmental Cell·Anne-Valerie GendrelEdith Heard
May 2, 2014·Trends in Genetics : TIG·Mélanie A Eckersley-Maslin, David L Spector
May 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gaëlle BougeardThierry Frebourg
Nov 19, 2015·The New England Journal of Medicine·Jinghui ZhangJames R Downing
Jul 20, 2019·The Journal of Pathology·Yuezhen XueDavid P Lane

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
confocal microscopy
PCR
flow cytometry

Software Mentioned

excel

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.